TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biovica International AB
Closing information (x1000 SEK)
Closing information | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
Turnover |
3,383
|
2,045
|
2,077 |
Financial expenses |
493
|
79
|
60 |
Earnings before taxes |
-110,680
|
-59,991
|
-39,386 |
EBITDA |
-102,243
|
-53,662
|
-34,039 |
Total assets |
172,288
|
151,631
|
192,650 |
Current assets |
119,990
|
94,914
|
147,266 |
Current liabilities |
23,638
|
16,094
|
8,595 |
Equity capital |
138,636
|
124,088
|
182,661 |
- share capital |
3,049
|
1,899
|
1,572 |
Employees (average) |
31
|
25
|
20 |
Financial ratios
Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
Solvency |
80.5%
|
81.8%
|
94.8% |
Turnover per employee |
109
|
82
|
104 |
Profit as a percentage of turnover |
-3271.7%
|
-2933.5%
|
-1896.3% |
Return on assets (ROA) |
-64.0%
|
-39.5%
|
-20.4% |
Current ratio |
507.6%
|
589.7%
|
1713.4% |
Return on equity (ROE) |
-79.8%
|
-48.3%
|
-21.6% |
Change turnover |
1,338
|
-32
|
406 |
Change turnover % |
65%
|
-2%
|
24% |
Chg. No. of employees |
6
|
5
|
3 |
Chg. No. of employees % |
24%
|
25%
|
18% |
Total value of public sale
Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.